Primary colon cancer with a high serum PIVKA-II level

[1]  J. Filmus,et al.  Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma. , 2011, Anti-cancer agents in medicinal chemistry.

[2]  Yoshihisa Takahashi,et al.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer. , 2010, World journal of gastrointestinal pathophysiology.

[3]  Y. Shiratori,et al.  Des-γ-carboxyl Prothrombin-promoted Vascular Endothelial Cell Proliferation and Migration* , 2007, Journal of Biological Chemistry.

[4]  E. Shimizu,et al.  Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation. , 2005, Anticancer research.

[5]  M. Miyazaki,et al.  PIVKA-II-producing advanced gastric cancer , 2004, International Journal of Clinical Oncology.

[6]  M. Makuuchi,et al.  Des-γ-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma , 2003 .

[7]  R. Bast,et al.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Y. Shiratori,et al.  Des‐γ‐carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma , 2001, Cancer.

[9]  Y. Ueno,et al.  Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma , 2000, American Journal of Gastroenterology.

[10]  Y. Ueno,et al.  Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. , 2000, The American journal of gastroenterology.

[11]  M. Matsuda,et al.  Colon cancer with a high serum alpha-fetoprotein level. , 1996, The American journal of gastroenterology.

[12]  J. Belghiti,et al.  Mechanism of the abnormal vitamin k‐dependent γ‐carboxylation process in human hepatocellular carcinomas , 1994, Cancer.

[13]  T. Maeda,et al.  Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha‐fetoprotein , 1994, Cancer.

[14]  J. Melamed,et al.  Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type , 1994, Cancer.

[15]  M. Tsuneyoshi,et al.  Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.

[16]  M. Kudo,et al.  Des-γ-carboxy prothrombin (PIVKA-II) and α-fetoprotein producing IIc-type early gastric cancer , 1992 .

[17]  M. Kudo,et al.  Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer. , 1992, The American journal of gastroenterology.

[18]  Ding‐Shinn Chen,et al.  Plasma des‐γ‐carboxyprothrombin in the early stage of hepatocellular carcinoma , 1990 .

[19]  J. Sung,et al.  Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. , 1990, Hepatology.

[20]  Shou-Dong Lee,et al.  Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma , 1984 .

[21]  B. Furie,et al.  Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. , 1984, The New England journal of medicine.

[22]  M. Herlyn,et al.  Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.

[23]  J. Stenflo,et al.  Vitamin K-dependent formation of gamma-carboxyglutamic acid. , 1977, Annual review of biochemistry.

[24]  T. Waldmann,et al.  Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract , 1975 .